Mental and physical health and coronavirus Mental and physical health support and information for people with cystic fibrosis (CF) during the coronavirus (COVID-19) crisis.
Kaftrio Read about the triple combination therapy Kaftrio (known as Trikafta in the United States), which combines ivacaftor, tezacaftor and elexacaftor, and find out how it could help to treat people with cystic fibrosis (CF).
Symkevi Read about Symkevi, which combines ivacaftor with tezacaftor, and find out how the drug could help to treat people with cystic fibrosis (CF).
Orkambi Orkambi (ivacaftor/lumacaftor) is the second precision medicine to be licensed for use in the UK by people with cystic fibrosis (CF).
How does cystic fibrosis affect the body? Find out how CF affects the body with our interactive body tool, as well as the symptoms and complications that CF causes.
Kalydeco Kalydeco is the first precision medicine for cystic fibrosis (CF) to be made available on the NHS.
Life-saving drugs campaign timeline Take a look at the latest updates in our campaign for fairer access to precision medicines in the UK for people with cystic fibrosis (CF).
Life-saving drugs FAQs Take a look at some of the frequently asked questions about life-saving drugs Kaftrio, Orkambi and Symkevi for people with cystic fibrosis.